Related Experiment Video
Updated: May 7, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
A possible link of gut microbiota alteration in type 2 diabetes and Alzheimer's disease pathogenicity: an update
Mohammad Z Alam, Qamre Alam, Mohammad A Kamal
1Fundamental and Applied Biology Group, Recombinant DNA Technology Unit, King Fahd Medical Research Centre, King Abdulaziz University, P. O. Box 80216, Jeddah 21589, Saudi Arabia. absar99@gmail.com.
Abstract:
Imbalances in gut microbiota are associated with metabolic disorder, which are a group of obesity-related metabolic abnormalities that increase an individual's risk of developing type 2 diabetes (T2D) and Alzheimer's disease (AD). Although a number of risk factors have been postulated that may trigger the development of AD, the root cause of this disease is still a matter of debate. This review further investigates the etiology of AD by accumulating the current role played by gut microbiota in human, and trying to establish an inter-link between T2D and AD pathogenesis. There is a growing body of evidence which suggests that obesity is associated with alteration in the normal gut flora, reduced bacterial diversity, metabolic pathways and altered representation of bacterial genes. Obesity and T2D are considered to be induced as a result of changes within the composition of gut microbiota. The evidence gathered so far clearly advocates the involvement of gut microbes in causing obesity, a state of chronic and low-grade inflammation. Hence, understanding the microbiota of the gut is significant in relation to inflammation, as it is a key contributor for diabetes which has a direct relation to the AD pathogenesis. Comparative analysis of gut microbiota may enable further novel insight into the complex biology of AD, which is very important in order to take preventive measure such as early diagnosis, identification of new therapeutic targets and development of novel drugs.
Insights
Gut microbiota imbalances are linked to metabolic disorders like obesity, type 2 diabetes (T2D), and Alzheimer
Area of Science:
- Microbiome research
- Neuroscience
- Metabolic disease research
Background:
- Gut microbiota imbalances are associated with metabolic disorders, increasing risks for type 2 diabetes (T2D) and Alzheimer's disease (AD).
- The etiology of AD remains debated, despite identified risk factors.
- Obesity is linked to altered gut flora, reduced bacterial diversity, and metabolic pathway changes.
Purpose of the Study:
- To investigate the role of gut microbiota in human health.
- To establish a link between T2D and AD pathogenesis.
- To explore the gut microbiota's contribution to obesity and inflammation.
Main Methods:
- Literature review and synthesis of current research on gut microbiota, T2D, and AD.
- Comparative analysis of gut microbiota composition.
- Accumulation of evidence on the role of gut microbes in metabolic disorders and neurodegeneration.
Main Results:
- Obesity and T2D are linked to changes in gut microbiota composition.
- Gut microbes are implicated in obesity, a state of chronic inflammation.
- Inflammation, driven by gut microbiota, is a key factor in diabetes and AD pathogenesis.
Conclusions:
- Understanding gut microbiota is crucial for addressing inflammation, diabetes, and AD.
- Comparative analysis of gut microbiota may offer insights into AD's complex biology.
- Further research can aid in early AD diagnosis, new therapeutic targets, and drug development.
Related Concept Videos
Gut-Brain Axis
Psychoneuroimmunology: Diabetes and Cancer
Type II Diabetes II: Pathophysiology
Alzheimer Disease l: Introduction
Introduction to the Human Microbiota
Type I Diabetes II: Pathophysiology
